We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$375M
AUM Growth
+$5.98M
Cap. Flow
-$10.7M
Cap. Flow %
-2.85%
Top 10 Hldgs %
17.55%
Holding
221
New
23
Increased
111
Reduced
62
Closed
17

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.47M
2
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.68M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$2.92M
4
CYBR
CyberArk
CYBR
+$2.32M
5
SANM icon
Sanmina
SANM
+$1.37M

Top Sells

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$10.2M
2
INGR icon
Ingredion
INGR
+$8.28M
3
MDU icon
MDU Resources
MDU
+$8.08M
4
DIS icon
Walt Disney
DIS
+$6.24M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$5.34M

Sector Composition

Rank Sector Weight
1 Healthcare 17.78%
2 Technology 15.38%
3 Industrials 12.46%
4 Consumer Staples 9.28%
5 Materials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMCSA icon
101
Comcast
CMCSA
$79.4B
$955K 0.25%
24,828
-125
-0.5% -$4.92K
WTRG icon
102
Essential Utilities
WTRG
$11.2B
$931K 0.25%
28,036
+1,781
+7% +$59.7K
RTN
103
DELISTED
Raytheon Company
RTN
$919K 0.25%
4,926
+27
+0.6% +$4.76K
SHY icon
104
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$897K 0.24%
10,626
-260
-2% -$22K
ORCL icon
105
Oracle
ORCL
$342B
$870K 0.23%
17,984
+1,032
+6% +$51.4K
LLL
106
DELISTED
L3 Technologies, Inc.
LLL
$851K 0.23%
4,514
+345
+8% +$61.9K
DD icon
107
DuPont de Nemours
DD
$18.7B
$849K 0.23%
+4,842
New +$808K
UPS icon
108
United Parcel Service
UPS
$97.6B
$847K 0.23%
7,054
+373
+6% +$42.4K
RGA icon
109
Reinsurance Group of America
RGA
$15.7B
$846K 0.23%
6,063
+433
+8% +$58.6K
CB icon
110
Chubb
CB
$138B
$814K 0.22%
5,711
+475
+9% +$68.7K
PRGS icon
111
Progress Software
PRGS
$1.55B
$813K 0.22%
21,293
+2,358
+12% +$78.8K
BR icon
112
Broadridge
BR
$17.1B
$807K 0.22%
9,988
+83
+0.8% +$6.39K
IEFA icon
113
iShares Core MSCI EAFE ETF
IEFA
$187B
$780K 0.21%
12,154
-116
-0.9% -$7.26K
ESNT icon
114
Essent Group
ESNT
$6.03B
$779K 0.21%
19,227
+2,254
+13% +$87.2K
PF
115
DELISTED
Pinnacle Foods, Inc.
PF
$775K 0.21%
13,556
+671
+5% +$39.8K
NDAQ icon
116
Nasdaq
NDAQ
$52.4B
$771K 0.21%
29,835
+1,464
+5% +$36.4K
AMAT icon
117
Applied Materials
AMAT
$434B
$759K 0.2%
14,570
+1,265
+10% +$57.2K
LOW icon
118
Lowe's Companies
LOW
$116B
$748K 0.2%
9,352
+428
+5% +$32.8K
CE icon
119
Celanese
CE
$5.18B
$747K 0.2%
7,160
+584
+9% +$57.4K
GIMO
120
DELISTED
Gigamon Inc.
GIMO
$741K 0.2%
+17,582
New +$717K
MTSC
121
DELISTED
MTS Systems Corp
MTSC
$734K 0.2%
13,738
+1,348
+11% +$67.9K
AMGN icon
122
Amgen
AMGN
$203B
$727K 0.19%
3,898
+325
+9% +$57.6K
GXP
123
DELISTED
Great Plains Energy Incorporated
GXP
$727K 0.19%
23,981
+1,659
+7% +$50.8K
EMN icon
124
Eastman Chemical
EMN
$7.85B
$725K 0.19%
8,011
+336
+4% +$28.6K
TWLO icon
125
Twilio
TWLO
$29.1B
$723K 0.19%
+24,234
New +$727K
3 4
5
6 7

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q3 2017 Portfolio in Review

As of Q3 2017, Stanley-Laman Group held 221 positions worth $375M, up 1.6% from $369M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Stanley-Laman Group's Q3 2017 filing shows 23 new, 111 increased, 62 reduced and 17 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M. The largest sale was Palo Alto Networks, an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

  • Stanley-Laman Group's largest Q3 2017 buy was BioMarin Pharmaceuticals: 73,226 shares worth $6.82M.
  • Stanley-Laman Group added most to Zix Corporation in Q3 2017, an estimated $1.31M increase.
  • Stanley-Laman Group's biggest Q3 2017 reduction was Palo Alto Networks, cutting an estimated $10.2M.
  • Stanley-Laman Group fully exited Supernus Pharmaceuticals in Q3 2017, selling an estimated $5.34M.
  • Stanley-Laman Group's ten largest holdings make up 18% of its $375M portfolio in Q3 2017.
  • Stanley-Laman Group opened 23 new positions and closed 17 in Q3 2017.
  • Stanley-Laman Group's portfolio value rose 1.6% quarter-over-quarter to $375M.

Based on Stanley-Laman Group's 13F filing for Q3 2017, filed 13 Nov 2017.